✦ LIBER ✦

A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with Novastan and TPA (MINT) study

✍ Scribed by Ik-Kyung Jang; David F.M Brown; Robert P Giugliano; H.Vernon Anderson; Douglas Losordo; Jose C Nicolau; Oscar P Dutra; Oscar Bazzino; Victor Molina Viamonte; Roberto Norbady; Alvaro Sosa Liprandi; Thomas J Massey; Robert Dinsmore; Richard P Schwarz Jr

Book ID: 119550572
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 261 KB
Volume: 33
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(99)00107-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized, Blinded Study of Two Doses

A Randomized, Blinded Study of Two Doses of Novastan® (Brand of Argatroban) Versus Heparin as Adjunctive Therapy to Recombinant Tissue Plasminogen Activator (Accelerated Administration) in Acute Myocardial Infarction: Rationale and Design of the Myocardial Infarction using Novastan® and T-PA (MINT) Study

✍ Ik-Kyung Jang; Robert P. Giugliano; Thomas J. Massey; Richard P. Schwarz 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 133 KB

Efegatran sulfate as an adjunct to strep

Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction

✍ Anthony Y. Fung; Gerald Lorch; Patrick A. Cambier; Dennis Hansen; Bradley G. Tit 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)

✍ Ik-Kyung Jang; Neil J. Weissman; Michael H. Picard; Michael R. Zile; Veronica Pe 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 264 KB

A Randomized, Double-Blind, Placebo-Cont

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Intravenous MCC-135 as an Adjunct to Primary Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction: Rationale and Design of the Evaluation of MCC-135 for Left Ventricular Salvage in Acute MI (EVOLVE) Study

✍ Ik-Kyung Jang; Veronica Pettigrew; Michael H. Picard; Peter R. Kowey; Valentin D 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 219 KB